EJJ-12244-11124
4 vaccinations
2 coded responses
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 021 / MA
- Registered
- 2021-04-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Dose 1 — Moderna
-
2021-04-19
Dose 2 — Moderna
-
2021-04-24
Registered in v-safe
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-04-25
- 2021-04-28
- 2021-07-21
- 2021-10-20
-
2021-10-27
Dose 3 — ModernaCo-administered: Flu
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-05
- 2021-11-17
- 2021-11-24
- 2021-12-02
- 2021-12-08
- 2022-04-27
-
2022-09-27
Dose 4 — ModernaCo-administered: Flu
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · NauseaAdult check-in
- 2022-09-30
- 2022-10-04
- 2022-10-13
- 2022-10-25
- 2022-11-01
- 2022-11-08
-
2022-12-27
Survey response — 3 months, dose 4MedDRA: Nasopharyngitis — Feeling: PoorFree text: Cold like symptomsMedDRA releases: 2024-11 · check-in free text available
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Moderna | |
| 2 | 2021-04-19 | Moderna | |
| 3 | 2021-10-27 | Moderna | Flu |
| 4 | 2022-09-27 | Moderna | Flu |
Free text
Release 12 — 3 months, dose 4
Symptoms: Cold like symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release